Legal Cannabis Market: Key Trends Shaping the Future of the Industry
Author : Manisha S | Published On : 07 Oct 2026
The legal cannabis market is transitioning from a highly restricted market into a rapidly developing regulated industry across multiple countries and regions. Expanding medical applications, changing regulatory frameworks, and increasing consumer acceptance are creating new opportunities for cultivators, manufacturers, distributors, and technology providers. Governments are also increasingly establishing regulated frameworks that can improve product safety, control supply chains, and generate tax revenues.
Key market values:
• 2024 Market Size: USD 69.7 billion
• 2026 Market Estimate: USD 89.0 billion
• 2033 Market Forecast: USD 216.8 billion
• CAGR, 2025–2033: 13.5%
• North America Revenue Share, 2024: 71.7%
The market's expansion reflects growing acceptance of cannabis-derived products for medical applications as well as the gradual liberalization of adult-use cannabis laws. In addition, improvements in cultivation, extraction, formulation, packaging, and distribution are helping companies develop more diverse and standardized products.
Key Market Segments
• By Source: Marijuana dominated the legal cannabis market with a 60.8% revenue share in 2024. Increasing adoption of medical marijuana for chronic conditions and the introduction of technologically advanced cannabis products are supporting the segment's leadership. Marijuana products include flowers as well as oil and tincture formats. Meanwhile, the hemp segment is anticipated to register the fastest CAGR during the forecast period. Demand for hemp is supported by its nutritional profile, fiber properties, and applications in personal hygiene, paper, building materials, textiles, oil and gas cleanup, and livestock bedding.
• By Derivative: CBD held the largest revenue share of 66.9% in 2024. CBD is a non-psychoactive cannabis compound that has gained popularity across wellness and health-related applications. The development of CBD-based gummies, oils, and other consumer products is expanding the product landscape. Meanwhile, the THC segment is expected to register a significant CAGR during the forecast period, supported by increasing acceptance of recreational cannabis in legalized markets and the development of innovative THC-containing products.
• By End Use: Medical use accounted for 63.6% of the global legal cannabis market revenue in 2024, making it the leading end-use segment. Growing acceptance of cannabis-based products for conditions such as chronic pain, cancer, arthritis, depression and anxiety, diabetes, epilepsy, and other health conditions is supporting demand. The recreational-use segment is also expected to experience significant growth, supported by expanding adult-use legalization, changing consumer attitudes, and new product formats such as edibles, beverages, and vape products.
• By Region: North America dominated the market with a 71.7% revenue share in 2024. A well-established healthcare infrastructure, high healthcare expenditure, increasing chronic pain prevalence, and relatively mature legal cannabis markets are supporting regional leadership. Europe is anticipated to register the fastest growth rate during the forecast period, supported by new product launches, regulatory developments, and increasing medical cannabis adoption.
Major Growth Drivers and Trends
• Expanding Cannabis Legalization: Regulatory liberalization remains one of the strongest growth factors. More countries and U.S. states are establishing legal frameworks for medical and adult-use cannabis. These frameworks can shift consumers away from unregulated channels toward regulated products while enabling governments to establish quality controls and collect tax revenues.
• Growing Medical Cannabis Adoption: Increasing acceptance of medical cannabis is supporting market expansion. Healthcare professionals and patients are showing greater interest in cannabis-derived products for symptom management and supportive care.
• Product Innovation: Cannabis companies are investing in improved cultivation methods, extraction technologies, and new product formats. Flowers, oils, tinctures, edibles, beverages, topicals, and other formulations are enabling companies to address different consumer preferences and applications. Product innovation is also helping businesses differentiate themselves in increasingly competitive regulated markets.
• Rising Recreational Demand: Adult-use legalization is creating new consumer markets across several regions. The availability of regulated products, broader retail networks, and changing social attitudes are supporting recreational cannabis consumption. Innovative products such as THC-infused beverages, edibles, and vape products are further expanding the recreational category.
• Increasing Investment and M&A Activity: The legal cannabis market is characterized by substantial merger and acquisition activity as companies seek to expand their geographic reach, production capabilities, and product portfolios. For example, Vireo Growth finalized a USD 102 million acquisition of Proper Brands in June 2025, strengthening its presence in Missouri.
• Regulatory Evolution: Regulatory frameworks continue to shape market access, product standards, licensing, packaging, labeling, and cultivation requirements. In April 2025, Canada introduced regulatory amendments that relaxed certain packaging and labeling restrictions and streamlined licensing criteria for small-scale producers. Such changes can improve operational flexibility while maintaining regulatory oversight.
Regional Market Outlook
North America remained the dominant regional market, accounting for 71.7% of global revenue in 2024. The region benefits from established healthcare infrastructure, high healthcare spending, and the increasing prevalence of chronic pain. The U.S. held the largest share of the North American legal cannabis market in 2024, supported by expanding medical and recreational markets and continued product innovation.
Europe is anticipated to register the fastest growth rate during the forecast period. Increasing medical cannabis approvals, new product introductions, and regulatory developments are creating favorable conditions for industry expansion. Germany, the UK, Switzerland, and other European markets are developing opportunities for medical cannabis companies as access and product availability expand.
Asia is projected to experience rapid growth as healthcare infrastructure improves, regulations evolve, and economic development attracts investment. Japan is gradually updating its cannabis-related regulations, while India's legal cannabis market is anticipated to register significant growth. In January 2025, Himachal Pradesh launched a pilot project for controlled cannabis cultivation for industrial and medicinal purposes, focusing on low-THC cultivation below 0.3%.
Latin America is also developing as awareness of cannabis-based medical and wellness applications increases. Brazil, Uruguay, Colombia, and other markets are evolving their regulatory frameworks and exploring opportunities associated with medical cannabis and controlled cultivation.
Looking for more specific insights? Customize this report to suite your business needs
Competitive Landscape
The legal cannabis market includes established cannabis companies, pharmaceutical businesses, medical cannabis specialists, and CBD-focused brands. Major companies profiled by Grand View Research include:
• Tilray Brands
• Canopy Growth Corporation
• Aurora Cannabis, Inc.
• Jazz Pharmaceuticals, Inc.
• The Cronos Group
• Organigram Holding, Inc.
• Tikun Olam
• ENDOCA
• Isodiol International, Inc.
• Medical Marijuana, Inc.
• NuLeaf Naturals, LLC
• Maricann Inc.
Companies are focusing on product portfolio expansion, partnerships, collaborations, mergers and acquisitions, international expansion, and cultivation capacity development to strengthen their market positions. International expansion is becoming particularly important as regulated cannabis markets emerge across Europe and other regions.
For instance, Tilray Medical launched three new medical cannabis flower varieties in Italy in June 2025, following approval from the Italian Ministry of Health. Such initiatives demonstrate how companies are expanding their presence in regulated international markets.
About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.
Explore Prism AI: Market Intelligence with Cited Research - https://www.grandviewresearch.com/prism-ai
